French health authorities on Monday recommended not using the anti-malaria drug chloroquine to treat COVID-19 cases, except under very restricted circumstances. But not everyone agrees with the decision.

French public biomedical research agency, Inserm, on Sunday announced it would coordinate a European trial, named Discovery, to evaluate four experimental treatments to fight the coronavirus.